Sanofi to Buy Colombian Drugmaker Genfar

Giant French pharmaceutical maker Sanofi said Tuesday it would buy Colombian drugmaker Genfar to expand its product portfolio in South America.

Genfar is Colombia's second-largest manufacturer of generic drugs with sales of $133 million last year, of which 30% was generated outside the country, Sanofi said in a statement announcing the purchase.

"Sanofi has a unique opportunity to strengthen its presence in Latin America through a large portfolio of affordable pharmaceuticals in a broad range of markets," the company's Latin America chief Heraldo Marchezini said in the statement.

Financial terms were not disclosed.